Leukemia (acute myeloic)

Acute myeloid leukaemia.
[9039730] Br Med Bull 52(4): 764-77 (1996)

Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia.
[19707379] Biologics 2(3): 491-500 (2008)

Clofarabine: in search of combinations for the treatment of patients with high-risk acute myeloid leukemia.
[18780321] Cancer 113(8): 1995-8 (2008)

Monitoring of minimal residual disease in acute myeloid leukemia.
[18000811] Cancer 112(1): 4-16 (2008)

Progress in the treatment of acute myeloid leukemia.
[17786921] Cancer 110(9): 1900-10 (2007)

Acute myeloid leukemia: epidemiology and etiology.
[17019734] Cancer 107(9): 2099-107 (2006)

New agents in acute myeloid leukemia and other myeloid disorders.
[14745859] Cancer 100(3): 441-54 (2004)

Therapeutic options for acute myelogenous leukemia.
[11571716] Cancer 92(5): 1059-73 (2001)

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
[11410481] Clin Cancer Res 7(6): 1490-6 (2001)

Immunotherapy of acute myeloid leukemia: current approaches.
[19289488] Oncologist 14(3): 240-52 (2009)

Acute myelogenous leukemia in older adults.
[19282349] Oncologist 14(3): 222-32 (2009)

Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
[17405900] Oncologist 12(3): 341-55 (2007)

Recent developments in acute myelogenous leukemia therapy.
[18039635] Oncologist 12 Suppl 2(-): 14-21 (2007)

Realistic pathologic classification of acute myeloid leukemias.
[11293903] Am J Clin Pathol 115(4): 552-60 (2001)

Drug therapy for acute myeloid leukemia.
[15870183] Blood 106(4): 1154-63 (2005)

Treatment of myelogenous leukemia: current status and investigational options.
[8605319] Blood 87(8): 3069-81 (1996)

Acute myelogenous leukemia: recent advances in therapy.
[3555647] Blood 69(6): 1551-62 (1987)

Molecular genetic pathways as therapeutic targets in acute myeloid leukemia.
[19074117] Hematology Am Soc Hematol Educ Program -(-): 400-11 (2008)

Acute myeloid leukemia: the challenge of capturing disease variety.
[19074046] Hematology Am Soc Hematol Educ Program -(-): 1-11 (2008)

Implication of the molecular characterization of acute myeloid leukemia.
[18024659] Hematology Am Soc Hematol Educ Program -(-): 412-9 (2007)

The molecular pathology of acute myeloid leukemia.
[16304371] Hematology Am Soc Hematol Educ Program -(-): 137-42 (2005)

Acute myeloid leukemia and acute promyelocytic leukemia.
[14633778] Hematology Am Soc Hematol Educ Program -(-): 82-101 (2003)

Adult acute myeloid leukemia.
[16471082] Mayo Clin Proc 81(2): 247-60 (2006)

Myeloid sarcoma: extramedullary manifestation of myeloid disorders.
[19687319] Am J Clin Pathol 132(3): 426-37 (2009)

A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia.
[20538803] Blood 116(13): 2205-14 (2010)

Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts.
[17412887] Blood 110(3): 799-805 (2007)

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.
[17008539] Blood 109(3): 874-85 (2007)

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
[19880497] Blood 115(3): 453-74 (2010)

Allogeneic stem cell transplantation for acute myeloid leukemia.
[20513804] Haematologica 95(6): 857-9 (2010)

Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity.
[11869944] Haematologica 87(3): 306-19 (2002)

Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum.
[21454879] Haematologica 96(4): 491-3 (2011)

Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help.
[20378574] Haematologica 95(4): 529-34 (2010)

Molecular characterization of acute myeloid leukemia.
[18591623] Haematologica 93(7): 976-82 (2008)

Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature.
[12935987] Haematologica 88(8): ECR28 (2003)

Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives.
[19050066] Haematologica 93(12): 1769-72 (2008)

Deregulation of apoptosis in acute myeloid leukemia.
[17229639] Haematologica 92(1): 81-94 (2007)

Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia.
[19951971] Haematologica 95(5): 819-28 (2010)

Childhood and adolescent lymphoid and myeloid leukemia.
[15561680] Hematology Am Soc Hematol Educ Program -(-): 118-45 (2004)

Independent prognostic factors for AML outcome.
[20008224] Hematology Am Soc Hematol Educ Program -(-): 385-95 (2009)

Optimal induction and post-remission therapy for AML in first remission.
[20008225] Hematology Am Soc Hematol Educ Program -(-): 396-405 (2009)

What is the role of reduced-intensity transplantation in the treatment of older patients with AML?
[20008226] Hematology Am Soc Hematol Educ Program -(-): 406-13 (2009)

New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues.
[21034669] Discov Med 10(53): 281-92 (2010)

Structural and functional alterations of FLT3 in acute myeloid leukemia.
[19549778] Clin Cancer Res 15(13): 4263-9 (2009)

Questions regarding frontline therapy of acute myeloid leukemia.
[20623787] Cancer 116(21): 4896-901 (2010)

High-dose cytosine arabinoside in the treatment of acute myeloid leukemia: Review of three randomized trials.
[16721819] Cancer 107(1): 116-24 (2006)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
[20507806] Health Technol Assess 14 Suppl 1(-): 69-74 (2010)

Topics in pediatric leukemia--acute myeloid leukemia.
[16369325] MedGenMed 7(1): 20 (2005)

Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin.
[19503782] Clin Interv Aging 4(-): 197-205 (2009)

The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.
[20671809] Oncotarget 1(2): 89-103 (2010)

Targeting mTOR for the treatment of AML. New agents and new directions.
[21680954] Oncotarget 2(6): 510-7 (2011)

Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation.
[17125917] Cancer Lett 251(2): 179-86 (2007)

Melanoma differentiation associated gene-7/interleukin-24 potently induces apoptosis in human myeloid leukemia cells through a process regulated by endoplasmic reticulum stress.
[20858700] Mol Pharmacol 78(6): 1096-104 (2010)

A noncanonical Flt3ITD/NF-kappaB signaling pathway represses DAPK1 in acute myeloid leukemia.
[22096027] Clin Cancer Res 18(2): 360-9 (2012)

Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
[19652076] J Clin Oncol 27(26): 4392-7 (2009)

Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications.
[21453545] J Hematol Oncol 4(-): 13 (2011)

Current findings for recurring mutations in acute myeloid leukemia.
[21917154] J Hematol Oncol 4(-): 36 (2011)

Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights.
[20416083] J Hematol Oncol 3(-): 17 (2010)

Novel postremission strategies in adults with acute myeloid leukemia.
[19468272] Curr Opin Hematol 16(2): 105-11 (2009)

Will newer tyrosine kinase inhibitors have an impact in AML?
[21130412] Best Pract Res Clin Haematol 23(4): 489-94 (2010)

Angiogenesis in acute myeloid leukemia and opportunities for novel therapies.
[21904549] J Oncol 2012(-): 128608 (2012)

MN1, a novel player in human AML.
[17698380] Blood Cells Mol Dis 39(3): 336-9 (2007)

New agents in acute myeloid leukemia: beyond cytarabine and anthracyclines.
[19679009] Curr Oncol Rep 11(5): 346-52 (2009)

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.
[20428194] Leukemia 24(6): 1128-38 (2010)

The role of CALM-AF10 gene fusion in acute leukemia.
[18094714] Leukemia 22(4): 678-85 (2008)

Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
[20445327] Korean J Lab Med 30(2): 117-21 (2010)

Exploiting cellular pathways to develop new treatment strategies for AML.
[20056334] Cancer Treat Rev 36(2): 142-50 (2010)

Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?
[20629523] Leuk Lymphoma 51(10): 1805-15 (2010)

Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.
[19569254] Hematol Oncol 27(4): 171-81 (2009)

Recent advances in the treatment of acute myeloid leukemia.
[20798782] F1000 Med Rep 2(-): 55 (2010)

Genetic abnormalities and challenges in the treatment of acute myeloid leukemia.
[21779483] Genes Cancer 2(2): 95-107 (2011)

Recurrent neurotropic chloroma: report of a case and review of the literature.
[21200413] Adv Hematol 2011(): 854240 (2011)

Activated leukemic oncogenes AML1-ETO and c-kit: role in development of acute myeloid leukemia and current approaches for their inhibition.
[21417999] Biochemistry (Mosc) 75(13): 1650-66 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Leukemia (acute myeloic).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Leukemia (acute myeloic).php on line 92